The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.103%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,958.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Bridgepoint buys ECP; Barratt cuts dividend

Wed, 06th Sep 2023 07:46

(Alliance News) - Stocks in London are called lower on Wednesday, as the recent uptick in oil prices sours the mood.

On Tuesday, the Saudi Arabian energy ministry said the kingdom's production cut of one million barrels per day which first took effect in July will continue "for another three months until the end of December 2023". Russia's export cut of 300,000 barrels per day will continue for the same period, Deputy Prime Minister Alexander Novak said in a separate statement.

Oil rose above USD90 for a barrel of Brent, helping to fuel fears of renewed inflationary pressures across the global economy.

"The central banks, including the [Federal Reserve], will have little choice but to keep their monetary policies sufficiently tight to prevent an uptick in inflation. That could mean further rate hikes, or keeping the rates at restrictive levels for longer, in which case, oil prices make a U-turn and cheapen due to recession and global demand concerns," said Ipek Ozkardeskaya, Swissquote Bank senior analyst.

In early UK company news, Barratt Developments reported lower annual completions, scaling back dividend payments and ruling out share buybacks for the time being. Bridgepoint, meanwhile, launched a GBP50 million buyback, and announced plans to acquire ECP GBP835 million, after which point it will split its chair and CEO roles.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called down 40.9 points, 0.6%, at 7,397.03

----------

Hang Seng: up 0.1% at 18,459.35

Nikkei 225: closed up 0.6% at 33,241.02

S&P/ASX 200: closed down 0.8% at 7,257.10

----------

DJIA: closed down 195.74 points, or 0.6%, at 34,641.97

S&P 500: closed down 0.4% at 4,496.83

Nasdaq Composite: closed down 0.1% at 14,020.95

----------

EUR: up at USD1.0736 (USD1.0713)

GBP: up at USD1.2580 (USD1.2564)

USD: down at JPY147.17 (JPY147.66)

GOLD: up at USD1,927.99 per ounce (USD1,926.63)

OIL (Brent): down at USD90.14 a barrel (USD90.31)

(changes since previous London equities close)

----------

ECONOMICS

----------

Tuesday's key economic events still to come:

11:00 CEST EU retail trade

11:00 IST Ireland unemployment

09:30 BST UK construction PMI

09:30 BST UK narrow money and reserve balances

07:00 EDT US MBA weekly mortgage applications survey

08:00 EDT US Fed Boston President Susan Collins speaks at New England Council breakfast event

08:30 EDT US international trade in goods and services

08:55 EDT US Johnson Redbook retail sales index

09:45 EDT US services PMI

10:00 EDT US ISM services PMI

10:00 EDT US retail trade

14:00 EDT US Federal Reserve Beige Book

16:30 EDT US API weekly statistical bulletin

----------

German factory orders saw a sharp fall in July, according to Destatis figures. On a monthly basis, they fell 11.7% in July, more than the 4.0% market consensus cited by FXStreet. June's figure was upwardly revised as a 7.6% rise from 7.0%. On an annual basis, orders were 10.5% behind July 2022, compared to a upwardly revised reading of 3.3% growth in June. "Much of the sharp decline in new orders in July 2023 is due to a very large order reported in the manufacture of air and spacecraft in June 2023," the statistics office explained.

----------

BROKER RATING CHANGES

----------

RBC cuts Hikma Pharmaceutical to 'sector perform' - price target 2,150 pence

----------

RBC cuts Hargreaves Lansdown price target to 875 (925) pence - 'sector perform'

----------

Goldman Sachs cuts boohoo price target to 43 (50) pence - 'neutral'

----------

COMPANIES - FTSE 100

----------

Homebuilder Barratt Developments reported bottom-line progress in its recently concluded financial year, despite lower completions. In the year to June 30, pretax profit rose 9.8% to GBP705.1 million from GBP642.3 million a year before, as revenue edged up just 1.0% to GBP5.32 billion from GBP5.27 billion. Completions fell 3.9% to 17,206 from 17,908, which the firm said reflected the market slowdown experienced from September 2022. On an adjusted basis, pretax profit fell 16% to GBP88.43 million as adjusted operating margin fell to 16.2% from 20.0%. It proposed a final dividend of 23.5 pence per share, bringing the annual total to 33.7p, behind the previous year's payout of 36.9p. It said there would be "no further share buybacks at this stage". "Whilst there remains a clear need for increased housebuilding in the UK, short-term demand has been impacted by mortgage affordability challenges," it noted. Barratt reiterated guidance for total home completions between 13,250 and 14,250 in financial 2024.

----------

COMPANIES - FTSE 250

----------

Bridgepoint said it has added Energy Capital Partners to its platform, in a cash and shares acquisition worth GBP835 million. "ECP is a market leader in value-add infrastructure specialising in energy transition and sustainability-focused investing," the private equity investor said. The acquisition will be subject to shareholder approval. Following the acquisition, it plans to split the roles of CEO and chair. William Jackson will be chair and continue to focus on the core private equity business. Meanwhile, managing partner Raoul Hughe, an "architect of both ECP and Bridgepoint Credit transactions", will become CEO from October 1. Hughes will lead the business on a day-to-day basis, and join the ECP board. Further, Bridgepoint announced plans for a new GBP50 million share buyback. It has current repurchased GBP43 million of its existing GBP50 million programme.

----------

GCP Infrastructure Investments said it has been unable to agree on structure and terms with RM Infrastructure Income of a possible combination, and has therefore terminated discussions. GCP Infra is a Jersey-based investment fund, which specialises in UK infrastructure. RMII is an investor in loans to infrastructure assets. Last month GCP Infra and GCP Asset Backed Income announced a proposed merger with RMII. GCP Asset Backed Income, also known as GABI, is a London-based UK asset backed loan investor. GCP Infra said it remains in discussions with GABI over a proposed combination of the two companies. "Heads of Terms have been agreed and a shareholder feedback exercise is being conducted," GCP Infra said. Meanwhile, RMII said it has decided to put forward proposals for a "managed wind-down" of the company

----------

OTHER COMPANIES

----------

UK-bound flights from a Greek Island have been cancelled as the region continues to be battered by severe rainstorms and widespread flooding. Storm Daniel is causing severe flooding across the region, with streams overflowing their banks and water sweeping cars into the sea. Jet2 said all its flights due to depart the island on Tuesday and Wednesday – five in total – have been cancelled. The airline said it was monitoring the forecast and will confirm new departure times as soon as possible. Four flights scheduled from the UK to the Island on Wednesday have also been cancelled.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 May 2022 07:09

Hikma's Siggi Olafsson stands down as CEO

(Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.

Read more
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.